Innovative Concepts in Drug Development Overview
- Year Founded
-
2007
- Status
-
Acquired/Merged
- Employees
-
5
- Latest Deal Type
-
M&A
Innovative Concepts in Drug Development General Information
Description
Provider of proprietary screening platforms designed to achieve targeted research to accelerate drug development and bring greater benefits to the patient. The company's platform helps to reduce product development costs by developing and making available the appropriate decision-making tools and product development technologies, enabling researchers to tackle some of the more difficult to treat diseases that are associated with high overall costs to society, such as neurodegenerative diseases.
Contact Information
Website
www.icdd-sas.comCorporate Office
- 800 Avenue du Château de Jouques
- 13420 Gemenos
- France
Corporate Office
- 800 Avenue du Château de Jouques
- 13420 Gemenos
- France
Innovative Concepts in Drug Development Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Merger/Acquisition | 01-Jan-2019 | 00.000 | Completed | Generating Revenue | ||
| 4. Grant | 01-Jan-2014 | 00.000 | Completed | Generating Revenue | ||
| 3. Later Stage VC | 15-Jan-2013 | 00.000 | 00.000 | Completed | Generating Revenue | |
| 2. Accelerator/Incubator | 29-Nov-2012 | $1.64M | Completed | Generating Revenue | ||
| 1. Capitalization | 01-Jan-2009 | $1.64M | $1.64M | Completed | Generating Revenue |
Innovative Concepts in Drug Development Patents
Innovative Concepts in Drug Development Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3262418-B1 | Diagnostic markers of cognitive impairments, kits and uses thereof | Active | 26-Feb-2015 | 00000000000 | |
| EP-3262418-A1 | Diagnostic markers of cognitive impairments, kits and uses thereof | Active | 26-Feb-2015 | 00000000000 | |
| CA-2924579-A1 | Method of screening for compounds useful in the treatment of huntington disease | Pending | 20-Sep-2013 | 00000000000 | |
| JP-2016531587-A | Method for screening compounds useful for treatment of huntington's disease | Pending | 20-Sep-2013 | 00000000000 | |
| US-20160223526-A1 | Method of screening for compounds useful in the treatment of huntington disease | Inactive | 20-Sep-2013 | G01N33/5079 |
Innovative Concepts in Drug Development Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Innovative Concepts in Drug Development Former Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| CDPS | Angel Group | Minority | 000 0000 | 000000 0 |
| Grand Delta Angels | Angel Group | Minority | 000 0000 | 000000 0 |
| Incubateur Impulse | Accelerator/Incubator | 000 0000 | 000000 0 | |
| Michael J. Fox Foundation | Limited Partner | 000 0000 | 000000 0 | |
| Région Sud Investissement | Venture Capital | Minority | 000 0000 | 000000 0 |
Innovative Concepts in Drug Development FAQs
-
When was Innovative Concepts in Drug Development founded?
Innovative Concepts in Drug Development was founded in 2007.
-
Who is the founder of Innovative Concepts in Drug Development?
Nathalie Compagnone Ph.D is the founder of Innovative Concepts in Drug Development.
-
Where is Innovative Concepts in Drug Development headquartered?
Innovative Concepts in Drug Development is headquartered in Gemenos, France.
-
What is the size of Innovative Concepts in Drug Development?
Innovative Concepts in Drug Development has 5 total employees.
-
What industry is Innovative Concepts in Drug Development in?
Innovative Concepts in Drug Development’s primary industry is Biotechnology.
-
Is Innovative Concepts in Drug Development a private or public company?
Innovative Concepts in Drug Development is a Private company.
-
What is Innovative Concepts in Drug Development’s current revenue?
The current revenue for Innovative Concepts in Drug Development is 000000.
-
How much funding has Innovative Concepts in Drug Development raised over time?
Innovative Concepts in Drug Development has raised $2.69M.
-
Who are Innovative Concepts in Drug Development’s investors?
CDPS, Grand Delta Angels, Incubateur Impulse, Michael J. Fox Foundation, and Région Sud Investissement are 5 of 6 investors who have invested in Innovative Concepts in Drug Development.
-
When was Innovative Concepts in Drug Development acquired?
Innovative Concepts in Drug Development was acquired on 01-Jan-2019.
-
Who acquired Innovative Concepts in Drug Development?
Innovative Concepts in Drug Development was acquired by GeneStore.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
